ARTICLE | Clinical News
Revolade eltrombopag regulatory update
November 1, 2010 7:00 AM UTC
The U.K.'s NICE issued guidance recommending against the use of Revolade eltrombopag in its approved indications - to treat chronic idiopathic thrombocytopenic purpura (ITP) in splenectomized patients...